바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

간질성 폐질환에 대한 수술적 폐생검의 의의 및 안전성

Safety and Significance of Surgical Lung Biopsy for Interstitial Lung Disease

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2007, v.63 no.1, pp.59-66
이유진 (충남의대)
정미경 (경기대학교)
이정은 (충남대학교)
정성수 (충남대학교)
김주옥 (충남대학교)
김선영 (충남대학교)
정재욱 (충남의대)
박지원 (충남의대)
신지영 (충남의대)
정선영 (충남의대)
박희선 (충남의대)
  • 다운로드 수
  • 조회수

초록

연구배경: 수술적 폐생검은 간질성 폐질환의 확진 및 환자의 치료와 예후 예측에 도움을 주며, 안전하게 시행할 수 있는 방법이다. 간질성 폐질환의 확진을 위해 수술적 폐생검을 한 환자들을 분석하여, 간질성 폐질환 환자에 있어서 수술적 폐생검의 안전성 및 의의를 규명하고자 한다.방 법: 2001년 1월부터 2006년 6월까지 충남대학교 병원에서 간질성 폐질환이 의심되어 확진을 위해서 수술적 폐생검을 시행 받은 70예 중, 간질성 폐질환으로 진단된 40명의 환자를 후향적으로 분석하였다.결 과: 연령 분포는 21세에서 77세까지로 평균은 56.4±16.1세이며, 총 40명의 환자 중 28명(70%)은 최소 개흉술을 시행하였고, 12명(30%)은 흉강경으로 폐조직 검사를 시행하였다. 수술적 폐생검 후 30일 전체 사망률과 90일 전체 사망률은 각각 15%와 20%이였다. 수술 후 90일 사망자(8명)와 생존자(32명)를 비교해 보면, 수술 전 추가적인 산소 요법이 필요했던 경우는 술후 90일 사망자가 100%(8명)이고, 생존자가 28.1%(9명)이었으며 (p=0.000), 수술 전 기계적 환기 요법을 하였던 경우는 술후 90일 사망자가 62.5%(5명)이고, 생존자가 12.5%(4명)으로 (p=0.000) 수술 후 사망률과 통계적 유의성을 보였다.

keywords
Surgical lung biopsy, Interstitial lung disease, Safety., Surgical lung biopsy, Interstitial lung disease, Safety.

Abstract

Background: Surgical lung biopsy is required to establish the etiology and stage of interstitial lung disease(ILD). and this procedure can be safe and meaningful for making clinical decisions. We wanted to determine the safety of surgical lung biopsy(SLB) in patients with interstitial lung disease(ILD). Methods: We conducted a retrospective review of 40 patients with suspected ILD and they underwent surgical lung biopsy from January 2001 to June 2006 at Chungnam University Hospital. We analyzed retrospectively according to their age, gender, pulmonary function, chest tube duration, the arterial blood gases, the procedural technique, and the requirement for supplemental oxygen and mechanical ventilation(MV) at the time of SLB. Results: The mean age of the patients was 56.4±16.13 years(range: 21 to 77 years). Overall, the 30-day and 90-day mortality rates were 15% and 20%, respectively. The predictors of perioperative mortality were either the need for mechanical ventilation(MV) at the time of SLB or the need for supplemental oxygen prior to undergoing SLB. Among the 32 patients who were 90-day survivors, the proportion of those patients using the oxygen supplement was 28.1% (n=9). All 8 patients who were 90-day non-survivors used oxygen supplement (p=0.000). The use of the MV was 12.5% (n=4) in the 90-day survivors (n=32) and 62.5% (n=5) in the 90-day non-survivors (n=8); there was a significant difference between the 90-day survivors and non-survivors (p=0.000). Conclusion: Patients who require MV and supplemental oxygen are associated with an increased risk for death following SLB. (Tuberc Respir Dis 2007; 63: 59-66)

keywords
Surgical lung biopsy, Interstitial lung disease, Safety., Surgical lung biopsy, Interstitial lung disease, Safety.

참고문헌

1.

(1995) Interstitial lung disease: a diagnostic approach,

2.

(2002) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias: This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001,

3.

(2003) Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia,

4.

(1999) The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study,

5.

(2001) Which biopsies in diffuse infiltrative lung diseases and when are these necessary? ,

6.

(1998) The role of open lung biopsy in the management and outcome of patients with diffuse lung disease ,

7.

(1997) Efficacy and safety of videothoracoscopic lung biopsy in the diagnosis of interstitial lung disease,

8.

current concepts of pathogenesis,

9.

(193-207.) 9.Shim YS. Recent advances in diffuse interstitial lung disease. Tuberc Respir Dis 1989,

10.

(2004) Diagnostic imaging of diffuse infiltrative disease of the lung,

11.

(1999) Advances in radiology for interstitial lung disease,

12.

Remington JS. Open lung biopsy in patients with Hodgkin`s disease and pulmonary infiltrates. Am Rev Respir Dis 1989,

13.

(194-9.) et al. Comparison of open versus thoracoscopic lung biopsy for diffuse infiltrative pulmonary disease. J Thorac Cardiovasc Surg 1993,

14.

Divertie MB. Open lung biopsy in patients with diffuse pulmonary infiltrates and acute respiratory failure. Am Rev Respir Dis 1988,

15.

Simon JS. Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. Chest 1993,

16.

Cameron EW. Efficacy of video assisted thoracoscopic lung biopsy an historical comparison with open lung biopsy. Thorx 1994,

17.

(1995) The role of thoracoscopy in the diagnosis of interstitial lung disease,

18.

(1999) The utility of open lung biopsy in patients requiring mechanical ventilation,

Tuberculosis & Respiratory Diseases